subcutaneous administration

2 trials

Sponsors

Tomoyuki Nishiura, Nishiura Tomoyuki

Conditions

Acquired Reactive Perforating CollagenosisPruritus of atopic dermatitis which is inadequately controlled by the currently available therapy

Phase 2

A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Nemolizumab in Patients with Acquired Reactive Perforating Collagenosis

Active, not recruitingJPRN-jRCT2021230034

Tomoyuki NishiuraAcquired Reactive Perforating Collagenosis

Start: 2023-12-04Target: 21Updated: 2026-06-29

Phase 3

A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-Center Study to Evaluate the Efficacy and Safety of nemolizumab in Japanese Infant and Pediatric Atopic Dermatitis Patients with moderate to severe pruritus

Active, not recruitingJPRN-jRCT2031230174

Nishiura TomoyukiPruritus of atopic dermatitis which is inadequately controlled by the currently available therapy

Start: 2023-06-25Target: 70Updated: 2026-06-29